Literature DB >> 19193653

Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 Gy/fraction for non-small cell lung cancer: analysis of clinical and dosimetric factors.

Dongryul Oh1, Yong Chan Ahn, Hee Chul Park, Do Hoon Lim, Youngyih Han.   

Abstract

OBJECTIVE: This study was undertaken to identify the factors predictive of radiation pneumonitis (RP) in 69 non-small cell lung cancer patients treated with thoracic radiation therapy only by 3 Gy fractions.
METHODS: A total of 69 patients who received only RT in daily 3 Gy were included in this study. Grade > or =3 RP was defined as an RP event. The cumulative incidence of RP was estimated and the correlations of the development of RP with the potential predictors were determined.
RESULTS: The cumulative incidence of events was 17.1% at 12 months. By univariate analysis, all clinical factors [age, performance status, weight loss, pre-RT forced expiratory volume in 1 s, tumour location, stage, RT dose and clinical target volume] were not associated with the risk of Grade > or =3 RP; however, all dosimetric factors [V5-50 and mean lung dose (MLD)] closely correlated with the development of RP. The receiver-operative characteristics (ROC) analysis revealed that MLD was the best predictors of Grade > or =3 RP (area under curve ROC = 0.937). By multivariate analysis, MLD was the only significant factor to be predictive of RP risk: the probability of Grade > or =3 RP was 3.7% when MLD < or = 16.1 Gy and 78.4% when MLD > 16.1 Gy.
CONCLUSIONS: Dosimetric parameters were valuable in predicting the development of RP.

Entities:  

Mesh:

Year:  2009        PMID: 19193653     DOI: 10.1093/jjco/hyn158

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  15 in total

1.  Pulmonary artery invasion, high-dose radiation, and overall survival in patients with non-small cell lung cancer.

Authors:  Cheng-Bo Han; Wei-Li Wang; Leslie Quint; Jian-Xin Xue; Martha Matuszak; Randall Ten Haken; Feng-Ming Spring Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-28       Impact factor: 7.038

2.  Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.

Authors:  Mitsuru Okubo; Tomohiro Itonaga; Tatsuhiko Saito; Sachika Shiraishi; Ryuji Mikami; Hidetugu Nakayama; Akira Sakurada; Shinji Sugahara; Kiyoshi Koizumi; Koichi Tokuuye
Journal:  Br J Radiol       Date:  2017-04-06       Impact factor: 3.039

3.  Functional dose-volume histograms for predicting radiation pneumonitis in locally advanced non-small cell lung cancer treated with late-course accelerated hyperfractionated radiotherapy.

Authors:  Dongqing Wang; Baosheng Li; Zhongtang Wang; Jian Zhu; Hongfu Sun; Jian Zhang; Yong Yin
Journal:  Exp Ther Med       Date:  2011-06-29       Impact factor: 2.447

Review 4.  Prediction of radiation pneumonitis in lung cancer patients: a systematic review.

Authors:  Xiao-Jing Zhang; Jian-Guo Sun; Jie Sun; Hua Ming; Xin-Xin Wang; Lei Wu; Zheng-Tang Chen
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-29       Impact factor: 4.553

5.  Radiotherapy for thoracic tumors: association between subclinical interstitial lung disease and fatal radiation pneumonitis.

Authors:  Shinsaku Yamaguchi; Takayuki Ohguri; Yuichi Matsuki; Katsuya Yahara; Hodaka Oki; Hajime Imada; Hiroyuki Narisada; Yukunori Korogi
Journal:  Int J Clin Oncol       Date:  2014-03-11       Impact factor: 3.402

6.  Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus.

Authors:  Feng-Ming Spring Kong; Timothy Ritter; Douglas J Quint; Suresh Senan; Laurie E Gaspar; Ritsuko U Komaki; Coen W Hurkmans; Robert Timmerman; Andrea Bezjak; Jeffrey D Bradley; Benjamin Movsas; Lon Marsh; Paul Okunieff; Hak Choy; Walter J Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-08       Impact factor: 7.038

7.  Validation of in-house knowledge-based planning model for advance-stage lung cancer patients treated using VMAT radiotherapy.

Authors:  Nilesh S Tambe; Isabel M Pires; Craig Moore; Christopher Cawthorne; Andrew W Beavis
Journal:  Br J Radiol       Date:  2020-01-06       Impact factor: 3.039

8.  Predictive factors for radiation pneumonitis in lung cancer treated with helical tomotherapy.

Authors:  Youngkyong Kim; Seong Eon Hong; Moonkyoo Kong; Jinhyun Choi
Journal:  Cancer Res Treat       Date:  2013-12-31       Impact factor: 4.679

9.  Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.

Authors:  Jae Myoung Noh; Jin Man Kim; Yong Chan Ahn; Hongryull Pyo; BoKyong Kim; Dongryul Oh; Sang Gyu Ju; Jin Sung Kim; Jung Suk Shin; Chae-Seon Hong; Hyojung Park; Eonju Lee
Journal:  Cancer Res Treat       Date:  2015-02-12       Impact factor: 4.679

10.  Development of the DVH management software for the biologically-guided evaluation of radiotherapy plan.

Authors:  Bokyong Kim; Hee Chul Park; Dongryul Oh; Eun Hyuk Shin; Yong Chan Ahn; Jinsung Kim; Youngyih Han
Journal:  Radiat Oncol J       Date:  2012-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.